Pfizer (PFE), Lilly (LLY) Announce Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain

Go back to Pfizer (PFE), Lilly (LLY) Announce Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 195.15 +1.26 (0.65%)
Previous Close $193.89    52 Week High $88.16 
Open $194.93    52 Week Low $67.88 
Day High $196.27    P/E 45.17 
Day Low $194.47    EPS $4.32 
Volume 1,118,160       

Pfizer Inc. (NYSE: PFE) Delayed: 39.17 -0.02 (0.05%)
Previous Close $39.19    52 Week High $37.39 
Open $39.16    52 Week Low $28.25 
Day High $39.87    P/E 23.74 
Day Low $39.05    EPS $1.65 
Volume 16,865,324